Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide and Azelastine in PAR
NCT00806754Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2006
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by AstraZeneca. Started Nov 2006; status: completed.
02
Drugs
ciclesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00806754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806754.